Multivalent Vaccine against Marek's Disease and Highly Pathogenic Avian Influenza Virus

Summary Protective immunity against avian influenza, H5N1 subtype, may be provided economically using a multivalent vaccine against both avian influenza and Marek’s disease, a common vaccination target in birds. Using a recombinant herpesvirus, Marek’s disease and avian influence, H5N1 subtype, antigens are persistently expressed. Eliciting antibodies against these antigens may provide protective immunity at a reduced per-unit cost.

Applications A multivalent vaccine against avian influenza and Marek’s disease. For Further Information Please Contact the Director of Business Development Michal Preminger Email: [email protected] Telephone: (617) 432-0920

Inventor(s): Jung, Jae

Type of Offer: Licensing

Contact Patent Owner or Broker


Next Patent »
« More Medical Patents

Share on      

CrowdSell Your Patent